PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.92%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.87%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1.68%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.68%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-2.71%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.45%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
25.02%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-7.05%
Negative OCF growth while NXPI is at 37.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-9.93%
Negative FCF growth while NXPI is at 94.26%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
66.42%
10Y revenue/share CAGR at 75-90% of NXPI's 79.10%. Bill Ackman would press for new markets or product lines to narrow the gap.
96.86%
5Y revenue/share CAGR 1.25-1.5x NXPI's 77.31%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
41.72%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
241.13%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
127.23%
5Y OCF/share CAGR 1.25-1.5x NXPI's 107.18%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
37.02%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
401.02%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
252.29%
5Y net income/share CAGR at 75-90% of NXPI's 328.95%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
93.61%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
91.65%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
10.40%
5Y equity/share CAGR at 50-75% of NXPI's 18.89%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-4.05%
Negative 3Y equity/share growth while NXPI is at 42.98%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
361.20%
Dividend/share CAGR of 361.20% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
355.42%
5Y dividend/share CAGR above 1.5x NXPI's 169.49%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
294.10%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-13.89%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.21%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-7.70%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-7.50%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-6.09%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.